본문 바로가기
  • Home

Anticancer activities of Papaya (Carica papaya): A Review

  • CELLMED
  • Abbr : CellMed
  • 2018, 8(4), pp.20-20
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine

Shabir ahmad Parray 1 Zahoor ahmad Parray 2 Javed ahmad Khan 1 Sharique Zohaib 1 Shagufta Nikhat 3

1Mohammadia Tibbia College
2Centre for Interdisciplinary Research in Basic Sciences
3Mansoora Malegaon Nashik,

Candidate

ABSTRACT

Cancer is considered one of the deadly diseases in the world. According to WHO cancer now causes more deaths than all coronary heart disease. The incidence and mortality of the worldwide major cancers are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The transition of global demographic and epidemiologic shows that burden of cancer will increase particularly in low and middle income countries, with over 20 million new cancer cases expected annually as early as 2025. Medicinal plants made known to be prospective and useful job for the treatment of several diseases and disorders from prehistoric days to nowadays. One of the commonly used plants, which have supporting evidences from the recent scientific data for the different types of cancers, is Carica papaya. Papaya (Carica papaya) is widely used as folk caloric herbal medicine, being a powerhouse of nutrients and accessible throughout the year. It is a rich source of three powerful antioxidants, the minerals, vitamins and contains high content of fibre. Carica papaya has provided many remedies for various diseases from ancient days to nowadays, and is regarded as a Nutraceutical. Because of this comprehensive medicinal value of Carica papaya, we are trying here to convey the reports studied especially for the anticancer activities of the age-old fruit, which will help researchers to pull in concert data and may be a “lead” for the one of the dangerous disease in the world.

Citation status

* References for papers published after 2022 are currently being built.